European Companies Search Engine
European Union Transparency Register Eutr9 May 2026 European Union Transparency Register
Overview
Text
European Union Transparency Register Entry: Daiichi Sankyo Europe GmbH
This report provides a human-readable summary of the transparency register data for Daiichi Sankyo Europe GmbH (DSE).
🏢 Organization Profile
- Name: Daiichi Sankyo Europe GmbH
- Acronym: DSE
- Identification Code: 284628150205-20
- Registration Category: Companies & groups
- Legal Form: GmbH
- Website: https://www.daiichi-sankyo.eu/
📍 Contact Information
| Office | Address | Phone |
|---|---|---|
| Head Office |
|
+49 8978080 |
| EU Office |
|
+49 8978080 |
🎯 Goals and Interests
Mission Statement: Daiichi Sankyo is a research-based global pharmaceutical company headquartered in Japan. Its European operations, based in Munich, focus primarily on cardiovascular diseases and oncology.
Primary Interests:
- Business and industry
- Digital economy and society
- Public health
- Research and innovation
- Trade
Legislative Focus: The organization monitors EU initiatives related to innovative medicines, including:
- General Pharmaceutical Legislation & Biotech Act I
- Urban Wastewater Treatment Directive & Critical Medicines Act
- EU Safe Hearts Plan & Clinical Trials
- Intellectual Property (IP), Trade, and Sustainability
📢 Activities and Memberships
Communication Activities
- Sponsorship of the Economist World Cancer Series (Women-Centric Breast Cancer Care).
- Participation in the European Health Forum Gastein (NCDs and women's health).
- Engagement in the European Business Summit regarding the EU Cardiovascular Health Plan.
- Roundtables with the European Cancer Organisation.
Memberships
The organization is a member of several influential groups:
- EFPIA (European Federation of Pharmaceutical Industries and Associations)
- EPC (European Policy Centre)
- European Cancer Organisation (E.C.O.)
- JBCE (Japanese Business Council in Europe)
- All.Can
👥 Human Resources
- Total Members: 3
- Full-Time Equivalent (FTE): ~0.7
- EP Accredited Persons: 2 (Individuals with access to European Parliament premises)
💰 Financial Information
Financial Year: April 1, 2025 – March 1, 2026
| Category | Details |
|---|---|
| Estimated Annual Lobbying Costs | €900,000 – €999,999 |
| Intermediary Used | Acumen Public Affairs |
| Intermediary Costs | €50,000 – €99,999 |
📅 Registration History
- Registered on: May 26, 2023
- Last Updated: May 8, 2026
- Data Export Date: May 15, 2026
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Daiichi Sankyo Europe GmbH, Munich, Germany.